It has been previously demonstrated that lncRNA XIST can control the growth and glucose metabolism in glioblastoma cells via the insulin receptor substrate 1 (IRS1)/the phosphoinositide 3-kinase (PI3K)/protein kinase B(Akt) pathway (Cheng et al., 2020). Here, AKT1 is linked to glioblastoma.